Skip to content
Home › 13F recaps › Q3 2026 › NVS

Which funds bought or sold NVS in Q3 2026?

Novartis Ag. 2 funds bought, 5 sold, out of 109 tracked funds that have filed for Q3 2026. Among active managers, the estimated net flow was −$222M.

Holdings as of Sep 30, 2026 (Q3 2026)13F deadline Nov 16, 2026 (45 days after quarter end)

PostLinkedIn
Who bought and who sold NVS, by estimated dollars
◀ SoldBought ▶

Top 10 each side. NEW = opened a position, OUT = sold the whole position.

Bought (2)

FundChangeEst. $Now
Citadel
Quant & multi-strategy
Added+403%+$184M$230M
Fisher Investments
Asset manager
Added+8%+$177M$2.4B

Sold (5)

FundChangeEst. $Now
GQG
Growth / crossover
Trimmed-97.8%−$300M$7M
Holocene
Hedge fund
Trimmed-54.1%−$80M$68M
Northern Trust
Bank & broker
Trimmed-9.3%−$37M$361M
Farallon
Hedge fund
Trimmed-29.8%−$15M$36M
Dodge & Cox
Value investor
Trimmed-3.2%−$3M$105M

Source: SEC EDGAR Form 13F-HR for each fund, holdings as of Sep 30, 2026. Shares only (options excluded). Estimated $ = change in shares × quarter-end price. Funds may have traded since. Methodology. Not investment advice.

Most bought in Q3 2026 → · Most sold →

Weekly digest · free

13F filings and guru moves, in one short email

A Sunday digest of what famous investors said and filed this week, plus an alert when someone changes stance. Free, no spam, unsubscribe anytime.